Download this file

# pmid doi year title Hugo_Symbol
1 35106936 10.1002/cam4.4550 2022 SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups. SGK1
2 32273478 10.3324/haematol.2020.251579 2021 Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphoma. SGK1
3 34272731 10.1111/bjh.17708 2021 EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features. SGK1
4 34378195 10.1111/bjh.17765 2021 Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort. SGK1
5 33252851 10.1002/ctm2.221 2020 Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma. SGK1
6 30213827 10.3324/haematol.2018.203224 2019 <i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma. SGK1
7 31203134 10.1016/j.biopha.2019.109092 2019 Estradiol promotes trophoblast viability and invasion by activating SGK1. SGK1
8 26229090 10.1158/2159-8290.CD-15-0370 2015 Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma. SGK1